Hydrogen Gas Reduces Lung Scarring in Animal Study
- Authors
- Li Gao, Dingyuan Jiang, Jing Geng, Run Dong, Huaping Dai
- Journal
- Experimental Physiology
- Year
- 2019
- DOI
- 10.1113/EP088028
- Study Type
- Rat
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Pulmonary Fibrosis
- Body System
- Respiratory
TL;DR
Breathing in hydrogen gas can reduce lung scarring and damage caused by a drug called bleomycin in rats.
Key Finding
Hydrogen gas inhalation reduced bleomycin-induced lung scarring in rats by lowering oxidative stress and blocking key proteins involved in the fibrosis process.
Summary
Researchers tested whether inhaling hydrogen gas could help treat pulmonary fibrosis (lung scarring) in rats. They found that hydrogen inhalation reduced lung damage caused by bleomycin (a chemotherapy drug) by decreasing harmful molecules called free radicals, blocking a protein called TGF-β1 that promotes scarring, and preventing lung cells from transforming into scar-forming cells.
Practical Takeaway
This rat study suggests hydrogen inhalation may have potential as a treatment for pulmonary fibrosis, but it is very early-stage research. Human clinical trials would be needed to determine whether these effects occur in people and whether hydrogen could be a safe and effective therapy for lung disease.
Abstract (excerpt)
New findings: • What is the central question of this study? The aim was to explore the effects and underlying mechanisms of H2 on bleomycin (BLM)-induced pulmonary fibrosis. • What are the main findings and its importance? Our results indicate that, in BLM-induced pulmonary fibrosis, H2 inhalation…